Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 49 Years of Age and 60 to 80 Years of Age.
Condition: Norovirus Acute Gastroenteritis Interventions: Biological: mRNA-1403; Biological: mRNA-1405; Biological: Placebo Sponsor: ModernaTX, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials